^Valladeau, Jenny; Dezutter-Dambuyant, Colette; Saeland, Sem. Langerin/CD207 Sheds Light on Formation of Birbeck Granules and Their Possible Function in Langerhans Cells. Immunologic Research. 2003,28 (2): 93–107.PMID 14610287.doi:10.1385/IR:28:2:93.
^Kawamura, Tatsuyoshi; Kurtz, Stephen E.; Blauvelt, Andrew; Shimada, Shinji. The role of Langerhans cells in the sexual transmission of HIV. Journal of Dermatological Science. 2005,40 (3): 147–55.PMID 16226431.doi:10.1016/j.jdermsci.2005.08.009.
^Dezutter-Dambuyant, C; Charbonnier, AS; Schmitt, D. Cellules dendritiques épithéliales et infection par HIV-1 in vivo et in vitro [Epithelial dendritic cells and HIV-1 infection in vivo and in vitro]. Pathologie Biologie. December 1995,43 (10): 882–8.PMID 8786894(法语).
^De Witte, Lot; Nabatov, Alexey; Pion, Marjorie; Fluitsma, Donna; De Jong, Marein A W P; De Gruijl, Tanja; Piguet, Vincent; Van Kooyk, Yvette; Geijtenbeek, Teunis B H. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nature Medicine. 2007,13 (3): 367–71.PMID 17334373.doi:10.1038/nm1541.
^Arbyn, M.; Castellsagué, X.; de Sanjosé, S.; Bruni, L.; Saraiya, M.; Bray, F.; Ferlay, J. Worldwide burden of cervical cancer in 2008. Annals of Oncology. 2011-12-01,22 (12): 2675–2686.ISSN 1569-8041.PMID 21471563.doi:10.1093/annonc/mdr015.
^Haedicke, Juliane; Iftner, Thomas. Human papillomaviruses and cancer. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 2013-09-01,108 (3): 397–402.ISSN 1879-0887.PMID 23830197.doi:10.1016/j.radonc.2013.06.004.
^Bosch, F. X.; Manos, M. M.; Muñoz, N.; Sherman, M.; Jansen, A. M.; Peto, J.; Schiffman, M. H.; Moreno, V.; Kurman, R. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. Journal of the National Cancer Institute. 1995-06-07,87 (11): 796–802.ISSN 0027-8874.PMID 7791229.doi:10.1093/jnci/87.11.796.
^Merad, Miriam; Ginhoux, Florent; Collin, Matthew. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nature Reviews. Immunology. 2008-12-01,8 (12): 935–947.ISSN 1474-1741.PMID 19029989.doi:10.1038/nri2455.
^Fausch, Steven C.; Da Silva, Diane M.; Rudolf, Michael P.; Kast, W. Martin. Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses. Journal of Immunology. 2002-09-15,169 (6): 3242–3249.ISSN 0022-1767.PMID 12218143.doi:10.4049/jimmunol.169.6.3242.
^Fausch, Steven C.; Da Silva, Diane M.; Kast, W. Martin. Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells. Cancer Research. 2003-07-01,63 (13): 3478–3482.ISSN 0008-5472.PMID 12839929.
^Fausch, Steven C.; Fahey, Laura M.; Da Silva, Diane M.; Kast, W. Martin. Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation. Journal of Immunology. 2005-06-01,174 (11): 7172–7178.ISSN 0022-1767.PMID 15905561.doi:10.4049/jimmunol.174.11.7172.
^Fahey, Laura M.; Raff, Adam B.; Da Silva, Diane M.; Kast, W. Martin. A major role for the minor capsid protein of human papillomavirus type 16 in immune escape. Journal of Immunology. 2009-11-15,183 (10): 6151–6156.ISSN 1550-6606.PMID 19864613.doi:10.4049/jimmunol.0902145.
^Langerhans, Paul. Ueber die Nerven der menschlichen Haut [On the nerves of the human skin]. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 1868,44 (2–3): 325–37.doi:10.1007/BF01959006(德语).